Immunotherapy-resistant neuropathic pain and fatigue predict quality-of-life in contactin-associated protein-like 2 antibody disease
The long-term clinical outcomes and associated prognostic factors in contactin-associated protein-like 2 (CASPR2)-antibody diseases are unknown. A total of 75 participants with CASPR2 antibodies were longitudinally assessed for disability, quality-of-life, and chronic pain. Although most symptoms im...
Main Authors: | Ceronie, B, Strippel, C, Uy, C, Paneva, S, Makuch, M, Soleimani, B, Turaga, S, Binks, S, Ramanathan, S, Michael, S, Varley, J, Easton, A, Themistocleous, A, John Dawes, Bennett, DL, Irani, A, Handel, AE, Irani, SR |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Wiley
2025
|
Similar Items
-
Immunotherapy responsive neuropathic pain associated with LGI1 and CASPR2 antibodies
by: Ramanathan, S, et al.
Published: (2021) -
Immunotherapy-responsive neuropathic pain and allodynia in a patient with glycine receptor autoantibodies: a case report
by: Soleimani, B, et al.
Published: (2023) -
The immunology underlying CNS autoantibody diseases
by: Cleaver, J, et al.
Published: (2024) -
Autoimmune encephalitis: recent clinical and biological advances
by: Varley, JA, et al.
Published: (2023) -
Immunotherapy in autoimmune encephalitis
by: Trewin, BP, et al.
Published: (2022)